Elanco Animal Health Inc (ELAN) with a beta value of 1.32 appears to be a promising investment opportunity.

On Monday, Elanco Animal Health Inc (NYSE: ELAN) was -3.34% down from the session before settling in for the closing price of $14.35. A 52-week range for ELAN has been $7.88 – $16.88.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 9.00%. When this article was written, the company’s average yearly earnings per share was at 3.52%. With a float of $488.17 million, this company’s outstanding shares have now reached $492.85 million.

Considering the fact that the conglomerate employs 9800 people, you should pay attention to its efficiency factor.

Elanco Animal Health Inc (ELAN) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Elanco Animal Health Inc stocks. The insider ownership of Elanco Animal Health Inc is 0.97%, while institutional ownership is 98.28%. The most recent insider transaction that took place on Mar 08 ’24, was worth 244,500. In this transaction Director of this company bought 15,000 shares at a rate of $16.30, taking the stock ownership to the 61,330 shares. Before that another transaction happened on Mar 08 ’24, when Company’s Director bought 3,100 for $16.29, making the entire transaction worth $50,494. This insider now owns 77,594 shares in total.

Elanco Animal Health Inc (ELAN) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 19.94 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 3.52% per share during the next fiscal year.

Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators

You can see what Elanco Animal Health Inc (ELAN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.55. Likewise, its price to free cash flow for the trailing twelve months is 52.19.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit 0.26 in the next quarter and is forecasted to reach 1.06 in one year’s time.

Technical Analysis of Elanco Animal Health Inc (ELAN)

Compared to the last year’s volume of 4.39 million, its volume of 5.23 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 7.23%. Additionally, its Average True Range was 0.44.

During the past 100 days, Elanco Animal Health Inc’s (ELAN) raw stochastic average was set at 42.78%, which indicates a significant increase from 2.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.11% in the past 14 days, which was lower than the 32.00% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $15.82, while its 200-day Moving Average is $12.93. Nevertheless, the first resistance level for the watch stands at $14.34 in the near term. At $14.80, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.07. If the price goes on to break the first support level at $13.60, it is likely to go to the next support level at $13.33. Now, if the price goes above the second support level, the third support stands at $12.87.

Elanco Animal Health Inc (NYSE: ELAN) Key Stats

There are 492,970K outstanding shares of the company, which has a market capitalization of 6.84 billion. As of now, sales total 4,417 M while income totals -1,231 M. Its latest quarter income was 1,035 M while its last quarter net income were -141,000 K.